Evolution from one autoimmune disorder to another. Epitope spreading?

Scand J Immunol. 2018 May;87(5):e12657. doi: 10.1111/sji.12657. Epub 2018 Mar 25.

Authors

P Karagianni¹, E Zampeli¹, H M Moutsopoulos¹

Affiliation

¹ Department of Pathophysiology, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.

PMID: 29486064
DOI: 10.1111/sji.12657

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adult
Anemia / diagnosis*
Anemia / therapy
Autoantibodies / blood
CD59 Antigens / immunology
Epitopes / immunology*
Herpesviridae / immunology*
Herpesviridae Infections / immunology*
Humans
Hyperlipoproteinemias / diagnosis*
Hyperlipoproteinemias / therapy
Immunosuppressive Agents / therapeutic use
Lipoprotein Lipase / immunology
Male
Methylprednisolone / therapeutic use
Molecular Mimicry
Plasmapheresis
Purpura, Thrombocytopenic, Idiopathic / diagnosis*
Purpura, Thrombocytopenic, Idiopathic / therapy
Receptors, Lipoprotein / immunology
Rituximab / therapeutic use
Thrombocytopenia / diagnosis*
Thrombocytopenia / therapy
Viral Proteins / immunology

Substances

Autoantibodies
CD59 Antigens
Epitopes
GPIHBP1 protein, human
Immunosuppressive Agents
Receptors, Lipoprotein
Viral Proteins
Rituximab
Lipoprotein Lipase
Methylprednisolone

Supplementary concepts

Chylomicronemia, Familial, due to Circulating Inhibitor of Lipoprotein Lipase